Vaccinex, Inc. (VCNX)
Develops antibody drugs to treat cancer, Alzheimer's, and immune diseases.
$0.83+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+4.8%
The outlook
VCNX is trading well below both its 50- and 200-day moving averages, sitting roughly midway in its 52-week range. Analyst coverage appears thin. The overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range43% of the way from its 52-week low to high
Market cap
$2.2M
52-wk high
$1.50
52-wk low
$0.31
50-day avg
$1.05
200-day avg
$0.95
Trailing P/E
—